Home › Triple-Negative Breast Cancer › Florida › St. Petersburg
Triple-Negative Breast Cancer clinical trials in St. Petersburg, FL
4 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around St. Petersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecruitingPhase 3
- Comprehensive Hematology Oncology ( Site 0091), St. Petersburg
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RecruitingPhase 3
- Florida Cancer Specialists - North ( Site 7002), St. Petersburg
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Florida Cancer Specialists North, St. Petersburg
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RecruitingObservational study
- Comprehensive Hematology Oncology (ONare Alliance, LLC / Exigent Research, LLC, St. Petersburg
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Arlington, VA20 studies
- Atlanta, GA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in St. Petersburg
- Non-Small Cell Lung Cancer21 studies
- Breast Cancer11 studies
- Obesity9 studies
- Overweight9 studies
- Colorectal Cancer8 studies
- Heart Failure8 studies
- Lung Cancer7 studies
- Endometrial Cancer6 studies
- Burkitt Lymphoma6 studies
- Ovarian Cancer6 studies
- Type 2 Diabetes5 studies
- COPD5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.